KRAS is of special interest in pancreatic carcinoma since more than 90% of pancreatic carcinomas and even non-invasive, low-grade dysplasia PanINs show a KRAS mutation [24]. The gene discussed is KRAS; the disease is exocrine pancreatic carcinoma.